APO Research

APO RESEARCH · REPORT

Bispecific and Multispecific Antibody Service

Selected research

Industry Growth & Trends

Global Bispecific and Multispecific Antibody Service Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Bispecific and Multispecific Antibody Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bispecific and Multispecific Antibody Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bispecific and Multispecific Antibody Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bispecific and Multispecific Antibody Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Bispecific and Multispecific Antibody Service market include evitria, WuXi Biologics, Sino Biological, Alloy Therapeutics, Biointron, Akeso, Inc, Absolute Antibody, Zymeworks and Genedata Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bispecific and Multispecific Antibody Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bispecific and Multispecific Antibody Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bispecific and Multispecific Antibody Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bispecific and Multispecific Antibody Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Bispecific and Multispecific Antibody Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bispecific and Multispecific Antibody Service Market by Company

evitria

WuXi Biologics

Sino Biological

Alloy Therapeutics

Biointron

Akeso, Inc

Absolute Antibody

Zymeworks

Genedata Biologics

Creative Biolabs

ACROBiosystems

Invenra

ProteoGenix

Bispecific and Multispecific Antibody Service Segment by Type

Biochemical Characterization Service

Structural Characterization Service

Functional Characterization Service

Others

Bispecific and Multispecific Antibody Service Segment by Application

Cancer Treatment

Autoimmune Diseases

Infectious Diseases

Others

Bispecific and Multispecific Antibody Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bispecific and Multispecific Antibody Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bispecific and Multispecific Antibody Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bispecific and Multispecific Antibody Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Bispecific and Multispecific Antibody Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Bispecific and Multispecific Antibody Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Bispecific and Multispecific Antibody Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Bispecific and Multispecific Antibody Service Market Share by Region (2021-2026) Table 4. Global Bispecific and Multispecific Antibody Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Bispecific and Multispecific Antibody Service Market Share by Region (2027-2032) Table 6. Global Bispecific and Multispecific Antibody Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Bispecific and Multispecific Antibody Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Bispecific and Multispecific Antibody Service Market Size Share by Type (2021-2026) Table 9. Global Bispecific and Multispecific Antibody Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Bispecific and Multispecific Antibody Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Bispecific and Multispecific Antibody Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Bispecific and Multispecific Antibody Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Bispecific and Multispecific Antibody Service Market Size Share by Application (2021-2026) Table 24. Global Bispecific and Multispecific Antibody Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Bispecific and Multispecific Antibody Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Bispecific and Multispecific Antibody Service Industry Trends Table 37. Bispecific and Multispecific Antibody Service Industry Drivers Table 38. Bispecific and Multispecific Antibody Service Industry Opportunities and Challenges Table 39. Bispecific and Multispecific Antibody Service Industry Restraints Table 40. Global Bispecific and Multispecific Antibody Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Company (2021-2026) Table 42. Global Bispecific and Multispecific Antibody Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Bispecific and Multispecific Antibody Service Key Company Headquarters & Area Served Table 44. Global Bispecific and Multispecific Antibody Service Company, Product Type & Application Table 45. Global Bispecific and Multispecific Antibody Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Bispecific and Multispecific Antibody Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. evitria Company Information Table 49. evitria Business Overview Table 50. evitria Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. evitria Bispecific and Multispecific Antibody Service Product Portfolio Table 52. evitria Recent Development Table 53. WuXi Biologics Company Information Table 54. WuXi Biologics Business Overview Table 55. WuXi Biologics Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. WuXi Biologics Bispecific and Multispecific Antibody Service Product Portfolio Table 57. WuXi Biologics Recent Development Table 58. Sino Biological Company Information Table 59. Sino Biological Business Overview Table 60. Sino Biological Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sino Biological Bispecific and Multispecific Antibody Service Product Portfolio Table 62. Sino Biological Recent Development Table 63. Alloy Therapeutics Company Information Table 64. Alloy Therapeutics Business Overview Table 65. Alloy Therapeutics Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Alloy Therapeutics Bispecific and Multispecific Antibody Service Product Portfolio Table 67. Alloy Therapeutics Recent Development Table 68. Biointron Company Information Table 69. Biointron Business Overview Table 70. Biointron Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biointron Bispecific and Multispecific Antibody Service Product Portfolio Table 72. Biointron Recent Development Table 73. Akeso, Inc Company Information Table 74. Akeso, Inc Business Overview Table 75. Akeso, Inc Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Akeso, Inc Bispecific and Multispecific Antibody Service Product Portfolio Table 77. Akeso, Inc Recent Development Table 78. Absolute Antibody Company Information Table 79. Absolute Antibody Business Overview Table 80. Absolute Antibody Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Absolute Antibody Bispecific and Multispecific Antibody Service Product Portfolio Table 82. Absolute Antibody Recent Development Table 83. Zymeworks Company Information Table 84. Zymeworks Business Overview Table 85. Zymeworks Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Zymeworks Bispecific and Multispecific Antibody Service Product Portfolio Table 87. Zymeworks Recent Development Table 88. Genedata Biologics Company Information Table 89. Genedata Biologics Business Overview Table 90. Genedata Biologics Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Genedata Biologics Bispecific and Multispecific Antibody Service Product Portfolio Table 92. Genedata Biologics Recent Development Table 93. Creative Biolabs Company Information Table 94. Creative Biolabs Business Overview Table 95. Creative Biolabs Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Creative Biolabs Bispecific and Multispecific Antibody Service Product Portfolio Table 97. Creative Biolabs Recent Development Table 98. ACROBiosystems Company Information Table 99. ACROBiosystems Business Overview Table 100. ACROBiosystems Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. ACROBiosystems Bispecific and Multispecific Antibody Service Product Portfolio Table 102. ACROBiosystems Recent Development Table 103. Invenra Company Information Table 104. Invenra Business Overview Table 105. Invenra Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Invenra Bispecific and Multispecific Antibody Service Product Portfolio Table 107. Invenra Recent Development Table 108. ProteoGenix Company Information Table 109. ProteoGenix Business Overview Table 110. ProteoGenix Bispecific and Multispecific Antibody Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. ProteoGenix Bispecific and Multispecific Antibody Service Product Portfolio Table 112. ProteoGenix Recent Development Table 113. North America Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Bispecific and Multispecific Antibody Service Market Share by Country (2021-2026) Table 116. North America Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Bispecific and Multispecific Antibody Service Market Share Forecast by Country (2027-2032) Table 118. Europe Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Bispecific and Multispecific Antibody Service Market Share by Country (2021-2026) Table 121. Europe Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Bispecific and Multispecific Antibody Service Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Bispecific and Multispecific Antibody Service Market Share by Country (2021-2026) Table 126. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Bispecific and Multispecific Antibody Service Market Share Forecast by Country (2027-2032) Table 128. Latin America Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Bispecific and Multispecific Antibody Service Market Share by Country (2021-2026) Table 131. Latin America Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Bispecific and Multispecific Antibody Service Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Bispecific and Multispecific Antibody Service Market Share by Country (2021-2026) Table 136. Middle East & Africa Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Bispecific and Multispecific Antibody Service Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Bispecific and Multispecific Antibody Service Product Image Figure 3. Global Bispecific and Multispecific Antibody Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Bispecific and Multispecific Antibody Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Bispecific and Multispecific Antibody Service Market Share by Region: 2025 VS 2032 Figure 6. Global Bispecific and Multispecific Antibody Service Market Share by Region (2021-2032) Figure 7. North America Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Biochemical Characterization Service Image Figure 13. Global Biochemical Characterization Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Structural Characterization Service Image Figure 15. Global Structural Characterization Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Functional Characterization Service Image Figure 17. Global Functional Characterization Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Bispecific and Multispecific Antibody Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Bispecific and Multispecific Antibody Service Market Share by Type 2025 VS 2032 Figure 22. North America Bispecific and Multispecific Antibody Service Market Size Share by Type (2021-2032) Figure 23. Europe Bispecific and Multispecific Antibody Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Share by Type (2021-2032) Figure 25. Latin America Bispecific and Multispecific Antibody Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Share by Type (2021-2032) Figure 27. Cancer Treatment Image Figure 28. Global Cancer Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Autoimmune Diseases Image Figure 30. Global Autoimmune Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Infectious Diseases Image Figure 32. Global Infectious Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Bispecific and Multispecific Antibody Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Bispecific and Multispecific Antibody Service Market Share by Application 2025 VS 2032 Figure 37. North America Bispecific and Multispecific Antibody Service Market Size Share by Application (2021-2032) Figure 38. Europe Bispecific and Multispecific Antibody Service Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Share by Application (2021-2032) Figure 40. Latin America Bispecific and Multispecific Antibody Service Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Bispecific and Multispecific Antibody Service Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Bispecific and Multispecific Antibody Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Bispecific and Multispecific Antibody Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Bispecific and Multispecific Antibody Service Market Share by Country (2021-2032) Figure 47. Europe Bispecific and Multispecific Antibody Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Bispecific and Multispecific Antibody Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Bispecific and Multispecific Antibody Service Market Share by Country (2021-2032) Figure 50. Asia-Pacific Bispecific and Multispecific Antibody Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Bispecific and Multispecific Antibody Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Bispecific and Multispecific Antibody Service Market Share by Country (2021-2032) Figure 53. Latin America Bispecific and Multispecific Antibody Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Bispecific and Multispecific Antibody Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Bispecific and Multispecific Antibody Service Market Share by Country (2021-2032) Figure 56. Middle East & Africa Bispecific and Multispecific Antibody Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Bispecific and Multispecific Antibody Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Bispecific and Multispecific Antibody Service Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Biochemical Characterization Service
  • Structural Characterization Service
  • Functional Characterization Service
  • Others
Applications
  • Cancer Treatment
  • Autoimmune Diseases
  • Infectious Diseases
  • Others
Companies covered
  • evitria
  • WuXi Biologics
  • Sino Biological
  • Alloy Therapeutics
  • Biointron
  • Akeso, Inc
  • Absolute Antibody
  • Zymeworks
  • Genedata Biologics
  • Creative Biolabs
  • ACROBiosystems
  • Invenra
  • ProteoGenix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Bispecific and Multispecific Antibody Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Bispecific and Multispecific Antibody Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Bispecific and Multispecific Antibody Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Bispecific and Multispecific Antibody Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Bispecific and Multispecific Antibody Service Market Size (2021-2032)
  8. 1.5.1 North America Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Bispecific and Multispecific Antibody Service Market Size Growth Rate (2021-2032)
2 Bispecific and Multispecific Antibody Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Biochemical Characterization Service
  3. 2.1.2 Structural Characterization Service
  4. 2.1.3 Functional Characterization Service
  5. 2.1.4 Others
  6. 2.2 Global Bispecific and Multispecific Antibody Service Market Size by Type
  7. 2.2.1 Global Bispecific and Multispecific Antibody Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Bispecific and Multispecific Antibody Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Bispecific and Multispecific Antibody Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Bispecific and Multispecific Antibody Service Market Size by Regions
  11. 2.3.1 North America Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Breakdown by Type (2021-2026)
3 Bispecific and Multispecific Antibody Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer Treatment
  3. 3.1.2 Autoimmune Diseases
  4. 3.1.3 Infectious Diseases
  5. 3.1.4 Others
  6. 3.2 Global Bispecific and Multispecific Antibody Service Market Size by Application
  7. 3.2.1 Global Bispecific and Multispecific Antibody Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Bispecific and Multispecific Antibody Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Bispecific and Multispecific Antibody Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Bispecific and Multispecific Antibody Service Market Size by Regions
  11. 3.3.1 North America Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Bispecific and Multispecific Antibody Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Bispecific and Multispecific Antibody Service Industry Trends
  2. 4.2 Bispecific and Multispecific Antibody Service Industry Drivers
  3. 4.3 Bispecific and Multispecific Antibody Service Industry Opportunities and Challenges
  4. 4.4 Bispecific and Multispecific Antibody Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Bispecific and Multispecific Antibody Service Revenue (2021-2026)
  2. 5.2 Global Bispecific and Multispecific Antibody Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Bispecific and Multispecific Antibody Service Key Company Headquarters & Area Served
  4. 5.4 Global Bispecific and Multispecific Antibody Service Company, Product Type & Application
  5. 5.5 Global Bispecific and Multispecific Antibody Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Bispecific and Multispecific Antibody Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Bispecific and Multispecific Antibody Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Bispecific and Multispecific Antibody Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 evitria
  2. 6.1.1 evitria Company Information
  3. 6.1.2 evitria Business Overview
  4. 6.1.3 evitria Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 evitria Bispecific and Multispecific Antibody Service Product Portfolio
  6. 6.1.5 evitria Recent Developments
  7. 6.2 WuXi Biologics
  8. 6.2.1 WuXi Biologics Company Information
  9. 6.2.2 WuXi Biologics Business Overview
  10. 6.2.3 WuXi Biologics Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 WuXi Biologics Bispecific and Multispecific Antibody Service Product Portfolio
  12. 6.2.5 WuXi Biologics Recent Developments
  13. 6.3 Sino Biological
  14. 6.3.1 Sino Biological Company Information
  15. 6.3.2 Sino Biological Business Overview
  16. 6.3.3 Sino Biological Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sino Biological Bispecific and Multispecific Antibody Service Product Portfolio
  18. 6.3.5 Sino Biological Recent Developments
  19. 6.4 Alloy Therapeutics
  20. 6.4.1 Alloy Therapeutics Company Information
  21. 6.4.2 Alloy Therapeutics Business Overview
  22. 6.4.3 Alloy Therapeutics Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Alloy Therapeutics Bispecific and Multispecific Antibody Service Product Portfolio
  24. 6.4.5 Alloy Therapeutics Recent Developments
  25. 6.5 Biointron
  26. 6.5.1 Biointron Company Information
  27. 6.5.2 Biointron Business Overview
  28. 6.5.3 Biointron Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biointron Bispecific and Multispecific Antibody Service Product Portfolio
  30. 6.5.5 Biointron Recent Developments
  31. 6.6 Akeso, Inc
  32. 6.6.1 Akeso, Inc Company Information
  33. 6.6.2 Akeso, Inc Business Overview
  34. 6.6.3 Akeso, Inc Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Akeso, Inc Bispecific and Multispecific Antibody Service Product Portfolio
  36. 6.6.5 Akeso, Inc Recent Developments
  37. 6.7 Absolute Antibody
  38. 6.7.1 Absolute Antibody Company Information
  39. 6.7.2 Absolute Antibody Business Overview
  40. 6.7.3 Absolute Antibody Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Absolute Antibody Bispecific and Multispecific Antibody Service Product Portfolio
  42. 6.7.5 Absolute Antibody Recent Developments
  43. 6.8 Zymeworks
  44. 6.8.1 Zymeworks Company Information
  45. 6.8.2 Zymeworks Business Overview
  46. 6.8.3 Zymeworks Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Zymeworks Bispecific and Multispecific Antibody Service Product Portfolio
  48. 6.8.5 Zymeworks Recent Developments
  49. 6.9 Genedata Biologics
  50. 6.9.1 Genedata Biologics Company Information
  51. 6.9.2 Genedata Biologics Business Overview
  52. 6.9.3 Genedata Biologics Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Genedata Biologics Bispecific and Multispecific Antibody Service Product Portfolio
  54. 6.9.5 Genedata Biologics Recent Developments
  55. 6.10 Creative Biolabs
  56. 6.10.1 Creative Biolabs Company Information
  57. 6.10.2 Creative Biolabs Business Overview
  58. 6.10.3 Creative Biolabs Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Creative Biolabs Bispecific and Multispecific Antibody Service Product Portfolio
  60. 6.10.5 Creative Biolabs Recent Developments
  61. 6.11 ACROBiosystems
  62. 6.11.1 ACROBiosystems Company Information
  63. 6.11.2 ACROBiosystems Business Overview
  64. 6.11.3 ACROBiosystems Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 ACROBiosystems Bispecific and Multispecific Antibody Service Product Portfolio
  66. 6.11.5 ACROBiosystems Recent Developments
  67. 6.12 Invenra
  68. 6.12.1 Invenra Company Information
  69. 6.12.2 Invenra Business Overview
  70. 6.12.3 Invenra Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Invenra Bispecific and Multispecific Antibody Service Product Portfolio
  72. 6.12.5 Invenra Recent Developments
  73. 6.13 ProteoGenix
  74. 6.13.1 ProteoGenix Company Information
  75. 6.13.2 ProteoGenix Business Overview
  76. 6.13.3 ProteoGenix Bispecific and Multispecific Antibody Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 ProteoGenix Bispecific and Multispecific Antibody Service Product Portfolio
  78. 6.13.5 ProteoGenix Recent Developments
7 North America
  1. 7.1 North America Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
  3. 7.3 North America Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
  3. 8.3 Europe Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
  3. 10.3 South America Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Bispecific and Multispecific Antibody Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Bispecific and Multispecific Antibody Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research